FDA Brief

Warning letters Devices

FDA warning letter to

Shenzhen Sunell Technology Corporation

High riskIssued Mar 4, 2021Posted Mar 4, 2021Center for Devices and Radiological Health

FDA warns Shenzhen Sunell over unapproved COVID-19 fever-screening cameras sold in U.S. without clearance.

What happened

FDA reviewed the company’s website on February 26, 2021, and found it offered four fever-screening cameras for sale in the U.S. with statements that they are intended for COVID-19 mitigation, prevention, treatment, diagnosis, or cure. FDA said the cameras lacked marketing approval, clearance, or authorization and that the firm had not notified FDA of intent to market them. FDA also noted the devices can scan multiple people at once, which can create public health risks if temperatures are incorrectly assessed.

What FDA found

  1. The website statements show the screening cameras are intended for COVID-19 use, making them devices under the law.

    section 201(h) of the Act, 21 U.S.C. § 321(h)
  2. The firm offers the fever-screening cameras for COVID-19 use without FDA marketing approval, clearance, or authorization, making them adulterated.

    section 501(f)(1)(B) of the Act, 21 U.S.C. § 351(f)(1)(B)
  3. The firm did not submit a 510(k) premarket notification to FDA for the devices, making them misbranded.

    section 502(o) of the Act, 21 U.S.C. § 352(o); section 510(k), 21 U.S.C. § 360(k)
  4. The products are introduced or delivered for introduction into interstate commerce even though they are adulterated and misbranded.

    section 301(a) of the Act, 21 U.S.C. § 331(a)

What FDA wants

FDA tells the company to take immediate action to stop selling the cameras for COVID-19 use and to email COVID-19-Task-Force-CDRH@fda.hhs.gov within 48 hours with the specific steps taken and documentation showing how recurrence will be prevented.

Who should pay attention

  • U.S. distributors and resellers of thermal cameras
  • employers and venues using fever-screening systems
  • regulatory teams for COVID-19 screening-device makers

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. AseptiKits, LLC

    AseptiKits marketed unapproved sterile-preparation device kits without FDA clearance or approval, FDA says.

    High risk
  2. Happiest Baby, Inc.

    FDA says Happiest Baby marketed unapproved SNOO sleep sacks and hospital bundle and mishandled complaints.

    High risk
  3. Estar Technologies Ltd

    FDA warns Estar Technologies over selling seven unapproved PRP/PRF device kits in the U.S. without clearance or approval.

    High risk
  4. ProDx Health

    FDA warns ProDx Health that its HIV sample self-collection kits are sold without marketing authorization.

    High risk